As shown in Table 2, there were no significant differences in the genotypes frequencies between the NAFLD and control groups regarding adiponectin rs1501299 (276G/T) polymorphism (χ 2 = 0.72, P = 0.697). The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.